CHEMED CORP
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
CHE$544.49+1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
| CONSOLIDATED STATEMENTS OF CHANGES | ||||||
|---|---|---|---|---|---|---|
| IN STOCKHOLDERS' EQUITY | ||||||
| Chemed Corporation and Subsidiary Companies | ||||||
| (in thousands, except per share data) · Deferred | ||||||
| Compensation | ||||||
| Treasury · Payable in | ||||||
| Capital · Paid-in · Retained · Stock- · Company | ||||||
| Stock | Capital | Earnings | at Cost | Stock | Total | |
| Balance at December 31, 2021 | $36,514 | $1,044,341 | $1,970,311 | $(2,430,094) | $2,201 | $623,273 |
| Net income | - | - | 249,624 | - | - | 249,624 |
| Dividends paid ($1.48 per share) | - | - | (22,017) | - | - | (22,017) |
| Stock awards and exercise of stock options (Note 4) | 282 | 106,619 | - | (43,932) | - | 62,969 |
| Purchases of treasury stock (Note 19) | - | - | - | (114,074) | - | (114,074) |
| Other | - | (1,061) | - | (45) | 46 | (1,060) |
| Balance at December 31, 2022 | $36,796 | $1,149,899 | $2,197,918 | $(2,588,145) | $2,247 | $798,715 |
| Net income | - | - | 272,509 | - | - | 272,509 |
| Dividends paid ($1.56 per share) | - | - | (23,502) | - | - | (23,502) |
| Stock awards and exercise of stock options (Note 4) | 388 | 190,835 | - | (57,796) | - | 133,427 |
| Purchases of treasury stock (Note 19) | - | - | - | (73,813) | - | (73,813) |
| Other | - | 539 | - | 166 | (165) | 540 |
| Balance at December 31, 2023 | $37,184 | $1,341,273 | $2,446,925 | $(2,719,588) | $2,082 | $1,107,876 |
| Net income | - | - | 301,999 | - | - | 301,999 |
| Dividends paid ($1.80 per share) | - | - | (27,092) | - | - | (27,092) |
| Stock awards and exercise of stock options (Note 4) | 238 | 144,878 | - | (45,947) | - | 99,169 |
| Purchases of treasury stock (Note 19) | - | - | - | (358,737) | - | (358,737) |
| Excise tax on share repurchase | - | - | - | (2,246) | - | (2,246) |
| Other | - | (1,975) | - | (142) | 141 | (1,976) |
| Balance at December 31, 2024 | $37,422 | $1,484,176 | $2,721,832 | $(3,126,660) | $2,223 | $1,118,993 |
| The Notes to Consolidated Financial Statements are integral parts of these statements. | ||||||
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.